The effects of Maxacalcitol therapy for the patients with secondary hyperparathyroidism on clinical symptoms, bone mineral density and parathyroid swelling
SLATOPOLSKY, E. Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25 dihydroxycholecarciferol in uremic patients. J Clin Invest. 1984, 74, 2136-2143
BROWN, AJ. Therapeutic uses of vitamin D analogues. Am J Kidney Dis. 2001, 38, S3-S19
CANNELLA, G. Evidence of healing of secondary hyperparathyroidism in chronically hemodialyzied uremic patients treated with long-term intravenous calcitriol. Kidney Int. 1994, 46, 1124-1132